-
The site was producing substances for both the Johnson & Johnson and AstraZeneca vaccines. But following a mix-up, the facility will focus solely on producing ingredients for the J&J vaccine.
-
Some Ohio colleges and universities will start vaccinating students the week of April 5, as many return from spring break. The on-campus COVID-19 vaccination clinics are part of Gov. Mike DeWine's plan to reach as many students as possible before they disburse across the state and country this summer.
-
Some 15 million Johnson & Johnson COVID-19 vaccine doses had to be discarded. It’s unclear if that will affect Ohio’s plans to continue its vaccine rollout.
-
The drug company says the problem involved one batch of a substance that goes into its coronavirus vaccine. But the contractor, Emergent BioSolutions, has a history of problems.
-
Unlike other vaccines, the Johnson & Johnson vaccine requires a single shot, but the number of doses available in Ohio is far less than the other two vaccines. Therefore, finding this specific vaccine has not been easy.
-
Ohio is now into its fourth month of distributing COVID-19 vaccines, an effort that's helped the state relax some restrictions and finally look forward to…
-
Four of the biggest American health companies have tentatively agreed to pay $26 billion to settle their opioid liability. Tax breaks could allow them to claw back $4 billion.
-
As the new Johnson & Johnson COVID-19 vaccine rolls out, the health care community is trying to ward off misconceptions about it. The vaccine's one-shot feature may be what wins many over.
-
This week, Catholic leaders expressed moral concerns about the Johnson & Johnson COVID-19 vaccine because it was produced in part using fetal cell lines from an abortion. They say Catholics should first opt for Pfizer or Moderna vaccines, which also used a fetal cell line in research, but not in production.
-
The Food and Drug Administration on Saturday granted an emergency use authorization for the COVID-19 vaccine developed by Johnson & Johnson.The vaccine is…